Nystatin prophylaxis and treatment in severely immunodepressed patients

Cochrane Database of Systematic Reviews

Volumn 2002, Issue 4, 2002, Pages

  Gøtzsche, Peter C ^a   Johansen, Helle Krogh ^a  

^a Nordic Cochrane Centre   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; NYSTATIN;

ANTIBIOTIC PROPHYLAXIS; HUMAN; IMMUNE DEFICIENCY; MYCOSIS; OPPORTUNISTIC INFECTION; REVIEW; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL;

AMPHOTERICIN B; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTICS, ANTIFUNGAL; FLUCONAZOLE; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES; NYSTATIN; OPPORTUNISTIC INFECTIONS; RANDOMIZED CONTROLLED TRIALS;

EID: 0036982289     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD002033     Document Type: Review

References (26)

1. Buchanan AG, Riben PD, Rayner EN, Parker SE, Ronald AR, Louie TJ. Nystatin prophylaxis of fungal colonization and infection in granulocytopenic patients: correlation of colonization and clinical outcome. Clinical and Investigative Medicine 1985;8:139-47.
2. Egger T, Gratwohl A, Tichelli A, Uhr M, Stebler Gysi C, Passweg J, et al.Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients. A prospective, randomized, single-center study. Supportive Care in Cancer 1995;3:139-46.
3. Ellis ME, Clink H, Ernst P, Halim MA, Padmos A, Spence D, et al.Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. European Journal of Clinical Microbiology & Infectious Diseases 1994;13:3-11.
4. Ellis ME, Qadri SM, Spence D, Halim MA, Ernst P, Clink H, et al.The effect of fluconazole as prophylaxis for neutropenic patients on the isolation of Candida spp. from surveillance cultures. The Journal of Antimicrobial Chemotherapy 1994;33:1223-8.
5. Epstein JB, Vickars L, Spinelli J, Reece D. Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation. Oral Surgery, Oral Medicine, and Oral Pathology 1992;73:682-9.
6. Feusner J, Robinson P, Seibel N, Reaman G, Waskerwitz M, Thompson C. Fluconazole (FLU) vs nystatin (NYS) for the prevention of fungal infection in neutropenic children receiving cytotoxic chemotherapy. Proceedings of the Annual Meeting of the American Society of Clinical Oncology 1994;13:Abstract A1533 (p. 444).
7. Flynn PM, Cunningham CK, Kerkering T, San Jorge AR, Peters VB, Pitel PA, et al.Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group. The Journal of Paediatrics 1995;127:322-8.
8. Groll AH, Just-Nuebling G, Kurz M, Mueller C, Nowak-Goettl U, Schwabe D, et al.Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer. The Journal of Antimicrobial Chemotherapy 1997;40:855-62.
9. Lumbreras C, Cuervas-Mons V, Jara P, del Palacio A, Turrion VS, Barrios C, et al.Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. The Journal of Infectious Diseases 1996;174:583-8.
10. Pons V, Greenspan D, Lozada-Nur F, McPhail L, Gallant JR, Tunkel A, et al.Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions. Clinical Infectious Diseases 1997;24:1204-7.
11. Powles R, Kulkarni S, Treleaven J, Hobbs K, Sirohi B, Bhagwati N, et al.Phase III randomized trial of Nyotran (liposomal nystatin) or amphotericin B for the empiric antifungal therapy in febrile neutropenic patients [abstract]. 41st Annual Meeting of the American Society of Hematology, New Orleans, Louisiana, 3-7 Dec 1999. Blood 1999;94 (10 Suppl 1):342a.
12. Savino JA, Agarwal N, Wry P, Policastro A, Cerabona T, Austria L. Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients. The Journal of Trauma 1994;36:20-5.
13. Tian D, Jian H, Cui X, et al.Prospective study of fluconazole in the prevention of fungal infections in neutropenic patients with acute leukemia and non-Hodgkins lymphoma. 20th International Congress of Chemotherapy, June 29 to July 3 1997, Sydney, Australia. 1997:87 abstract no 3246.
14. Van Delden C, Lew DP, Chapuis B, Rohner P, Hirschel B. Antifungal Prophylaxis in Severely Neutropenic Patients: How Much Fluconazole is Necessary?. Journal of Clinical Microbiology and Infection 1995;1(1):24-30.
15. Young GA, Bosly A, Gibbs DL, Durrant S. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group. European Journal of Cancer 1999;35(8):1208-13.
16. Carpentieri U, Haggard ME, Lockhart LH, Gustavson LP, Box QT, West EF. Clinical experience in prevention of candidiasis by nystatin in children with acute lymphocytic leukemia. The Journal of Pediatrics 1978;92:593-5.
17. DeGregorio MW, Lee WM, Ries CA. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Cancer 1982;50:2780-4.
18. Epstein JB, Truelove EL, Hanson-Huggins K, Mancl LA, Chen A, Press OW, et al.Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2004;12(7):517-25.
19. Hoppe JE, Friess D, Niethammer D. Orointestinal yeast colonization of paediatric oncologic patients during antifungal prophylaxis: results of quantitative culture and Candida serology and comparison of three polyenes. Mycoses 1995;38:41-9.
20. Williams C, Whitehouse JM, Lister TA, Wrigley PF. Oral anticandidal prophylaxis in patients undergoing chemotherapy for acute leukemia. Medical and Pediatric Oncology 1977;3:275-80.
21. Gøtzsche PC, Johansen HK. Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia. BMJ 1997;314:1238-44.
22. Gøtzsche PC, Johansen HK. Routine versus selective antifungal administration for control of fungal infections in patients with cancer. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD000026].
23. Ninane J. A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group. European Journal of Clinical Microbiology and Infectious Diseases 1994;13:330-7.
24. Working Party of the British Society for Antimicrobial Chemotherapy. Antifungal drug chemotherapy. Antifungal drug susceptibility testing. The Journal of Antimicrobial Chemotherapy 1995;36:899-909.
25. Gøtzsche PC, Johansen HK. Nystatin prophylaxis and treatment in severely immunodepressed patients. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD002033].
26. Johansen HK, Gøtzsche PC. Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis. JAMA 1999;282:1752-9.